Roche Bi-Specific Antibody Approved by FDA for a Relapsed or Refractory Form of Non ...

Retrieved on: 2022-12-27 18:38:11

Tags for this article:

Click the tags to see associated articles and topics

Roche Bi-Specific Antibody Approved by FDA for a Relapsed or Refractory Form of Non .... View article details on hiswai:

Excerpt

Late last week, big pharma company Roche announced FDA approval of its bi-specific antibody Lunsumio for the treatment of people with a relapsed ...

Article found on: www.insideprecisionmedicine.com